Forbion closes co-investment fund on €75m

Forbion set up the vehicle to invest in up to six later-stage companies within the firm's FCF II portfolio with additional capital. Injections from Co-invest Fund I will go into final financing rounds before exit. Forbion's FCF II was launched in September 2010. The VC will inject between €5-20m per transaction.

LPs in FCF II, Coller Capital, Hamilton Lane and KLP, are among the investors that subscribed to the co-investment fund, which was launched in June this year. 

Investments
The VC has already deployed equity from the vehicle. One of the portfolio companies, Cellnovo, listed on Euronext Paris two months ago. The other two backed companies are Dezima Pharma, whose €9.8m series-A was led by Forbion in February 2013, and New York-based Exosome Diagnostics, whose $20m series-A in 2010 was also led by the GP.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Venture
• Benelux
• Netherlands